Physician
Piedmont Interventional Pain Care, PA
Piedmont Interventional Pain Care, PA was paid $150K by Medicaid between Jan 2018 and Nov 2024, across 16 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 32% of everything it billed.
33Billing provider infoPIEDMONT INTERVENTIONAL PAIN CARE, PA
SALISBURY, NC 28147
SALISBURY, NC 28147
33aNPI1952346793assigned 06/17/2006
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$150K
24GClaims7,874
24DCodes billed16
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in North Carolina
Rank by total paid#19 of 43
Median peer was paid$90K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILSON, ROBERT controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,202 | $41K | |
| 2019 | 1,673 | $27K | |
| 2020 | 1,158 | $21K | |
| 2021 | 1,056 | $20K | |
| 2022 | 450 | $13K | |
| 2023 | 666 | $12K | |
| 2024incomplete | 669 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 32% | 1,883 | 1,678 | $49K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 2,021 | 1,878 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 776 | 599 | $22K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 13% | 683 | 652 | $19K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 7.1% | 189 | 165 | $11K |
| 64483 | 1.1% | 21 | 12 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 262 | 237 | $754.42 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 359 | 324 | $263.94 |
| J3490 | Unclassified drugs | <1% | 938 | 830 | $35.35 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 140 | 113 | $7.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 112 | 92 | $4.56 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 300 | 284 | $0.00 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILSON, ROBERT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Bayou Tox, LLC | Gonzales, LA | $7.70M |
| Covenant Family Practice, PC | Clarksville, TN | $4.98M |
| Smile Center for Kids PLLC | El Paso, TX | $2.10M |
| Smile Center for Kids I PLLC | El Paso, TX | $1.97M |
| Abc Family Counseling, INC. | Anoka, MN | $385K |
| Lakeview Local Schools | Cortland, OH | $218K |
| Wilson Family Eyecare PS | Prosser, WA | $94K |
| Robert L. Wilson DDS, P.A. | Heber Springs, AR | $41K |
| Kenton City Office of Auditor | Kenton, OH | $32K |
| Anderson Creek Emergency Services INC. | Spring Lake, NC | $15K |
| DR. Robert a Wilson, MD PA | Greenville, SC | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.